Chinmay Jani, Chief Fellow, Hematology and Oncology at Sylvester Comprehensive Cancer Center at University of Miami, shared a post on X about an article he and his colleagues authored:
“Check out our recent editorial on the C-Brain trial for NSCLC brain metastases. Triplet therapy (RT + camrelizumab + chemo) showed 6-mo PFS 71.7%, strong intracranial responses and symptom relief. Promising, but randomized validation needed.”
Title: Evolving strategies in the management of non-small cell lung
Authors: Chinmay T. Jani, Gilberto Lopes, Zhonglin Hao, Aman Chauhan
More posts featuring Chinmay Jani on OncoDaily.